Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview

1136studies shown

Showing 1,009-1,020 of 1,136

Drug study icon

TerminatedNCT04722666

MIJ821 for depression

This study was terminated in the United States, in Canada, in Argentina, .... It is testing MIJ821 for depression.

In Canada

Depression, SuicidalityDrugFrom 18 Years to 65 Years

Countries: United States, Canada, Argentina, ...
Sponsor: Novartis Pharmaceuticals
Condition: Depression, Suicidality

Drug study icon

CompletedNCT00107926

Licarbazepine in the Treatment of manic episodes of Bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In Canada

BipolarityDrugFrom 18 Years to 70 Years

Countries: United States, Canada, Austria, ...
Sponsor: Novartis Pharmaceuticals
Condition: Bipolarity

Device study icon

SuspendedNCT02018185

Magnetic Brain Stimulation in Treatment of OCD

This summary needs review. Please check the official study record and contact the research team for details.

In Canada

OCDDeviceFrom 18 Years to 80 Years

Countries: Canada
Sponsor: University of Manitoba
Condition: OCD

Drug study icon

CompletedNCT01515423

Paliperidone Palmitate 3 Month and 1 Month Formulations for people with Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Canada

SchizophreniaDrugFrom 18 Years to 70 Years

Countries: United States, Australia, France, ...
Sponsor: Janssen Research & Development, LLC
Condition: Schizophrenia

Drug study icon

CompletedNCT00056472

Pharmacotherapy of Psychotic Depression

This summary needs review. Please check the official study record and contact the research team for details.

In Canada

Depression, SchizophreniaDrugOver 18 Years

Countries: United States, Canada
Sponsor: Weill Medical College of Cornell University
Condition: Depression, Schizophrenia

Behavioral study icon

CompletedNCT03485287

Safety and Effects of MDMA-assisted Psychotherapy for Treatment of PTSD (Canada)

This summary needs review. Please check the official study record and contact the research team for details.

In Canada

PTSDBehavioralOver 18 Years

Countries: Canada
Sponsor: Resilient Pharmaceuticals
Condition: PTSD

Other study type icon

CompletedNCT05546281

the Characteristics of Orthorexia Nervosa in the Population Living with Type 1 Diabetes

This summary needs review. Please check the official study record and contact the research team for details.

In Canada

Eating disordersOtherFrom 18 Years to 35 Years

Countries: Canada
Sponsor: Laval University
Condition: Eating disorders

Drug study icon

WithdrawnNCT02286206

the Effect of Dosing on Clozapine Levels

This summary needs review. Please check the official study record and contact the research team for details.

In Canada

SchizophreniaDrugFrom 19 Years to 65 Years

Countries: Canada
Sponsor: University of British Columbia
Condition: Schizophrenia

Drug study icon

CompletedNCT01396421

the Effectiveness of Three Different Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Canada

SchizophreniaDrugFrom 18 Years to 65 Years

Countries: United States, Canada, Japan, ...
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition: Schizophrenia

Drug study icon

WithdrawnNCT02213887

the Effects of Pantoprazole on Levels of Prescribed Psychiatric Medications

This summary needs review. Please check the official study record and contact the research team for details.

In Canada

SchizophreniaDrugFrom 19 Years to 65 Years

Countries: Canada
Sponsor: University of British Columbia
Condition: Schizophrenia

Drug study icon

CompletedNCT02731612

the Efficacy of Lurasidone in Cognitive Functioning in Bipolar Patients

This study exists to see whether a therapy or guided support program can make care clearer and more responsive. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

In Canada

BipolarityDrugFrom 19 Years to 65 Years

Countries: United States, Canada, United Kingdom, ...
Sponsor: Lakshmi N Yatham
Condition: Bipolarity

Other study type icon

CompletedNCT01754298

Two Surgical Drilling Techniques to Treat Juvenile Osteochondritis Dissecans of the Knee

This summary needs review. Please check the official study record and contact the research team for details.

In Canada

OCDOtherFrom 8 Years to 18 Years

Countries: United States, Canada
Sponsor: Boston Children's Hospital
Condition: OCD

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.